p 30 kg/m 2 ) In a post hoc analysis, patients randomized to Wegovy HD (N=1,005) had a mean baseline BMI of 2 After 72 weeks on Wegovy HD (N=950), along with diet and exercise, 43.2% reached a BMI vs 8.2% of patients on placebo Limitations 2 : This analysis was not prespecified in the study protocol and was not controlled for multiplicity Post hoc analyses are hypothesis generating and clinical validity cannot be determined # Observed data include only patients who had a body-weight assessment at week 72 (950 of 1,005 for Wegovy HD 7.2 mg injection arm and 171 of 201 for placebo arm) and do not include all randomized patients
Injection site issues arise : Redness, swelling, or pain at the injection site should be addressed
Children and Adolescents This medicine should not be given to children and adolescents under 18 years of age because it has not been studied in this age group
No, Jardiance is an oral medication, typically taken as a once-daily pill
Is There Really Anything to Be Afraid of in Using Semaglutide
Administration: Novo Semaglutide is usually administered via subcutaneous injection (under the skin), preferably in the thigh, abdomen, or upper arm